id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-6736-0002,FDA,FDA-2017-E-6736,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2017-12-05T05:00:00Z,2017,12,2017-12-05T05:00:00Z,,2017-12-05T13:22:16Z,,0,0,0900006482cdbbf0
FDA-2017-E-6736-0001,FDA,FDA-2017-E-6736,"Patent Extension Application from Squire Patent Boggs (US) LLP (on behalf of Lexicon Pharmaceuticals, Inc.)",Other,Application,2017-12-05T05:00:00Z,2017,12,2017-12-05T05:00:00Z,,2017-12-05T13:18:04Z,,0,0,0900006482cdbbee